ESC 365 - Impact of coronary flow reserve on the mortality and major adverse cardiac and cerebrovascular event in hemodialysis patients, regardless of diabetes.

ESC Professional Premium Access

Impact of coronary flow reserve on the mortality and major adverse cardiac and cerebrovascular event in hemodialysis patients, regardless of diabetes.

Session: Renal failure and clinical outcomes

Topic: Renal Failure and Cardiovascular Disease

Speaker: Doctor S. Ohshima (Nagoya, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Satoru Ohshima

Nagoya Kyoritsu Hospital, Nagoya (Japan)

0 follower

6 more presentations in this session

Glomerular filtration rate predicts pro-vascular progenitor cell depletion: insights from the IPE-PREVENTION and ORIGINS-RCE studies

Speaker: Mr E. Bakbak (Toronto, CA)

Development, validation, and comparative analysis of a simple clinical and laboratory-based risk score system for predicting and stratifying moderate-to-severe AKI after cardiac surgery

Speaker: Doctor J. Zeng (Beijing, CN)

Impact of mildly reduced kidney function on 5-year mortality in patients with STEMI treated with primary PCI

Speaker: Doctor M. Klaric (Belgrade, RS)

Incidence of major cardiovascular outcomes in patients with chronic kidney disease by severity: a United States population-based study using electronic medical records

Speaker: Doctor B. Tyl (La Garenne Colombes Cedex, FR)

Prolonged fibrinolysis time is a risk factor for mortality in patients with chronic kidney disease - a propensity score matched analysis

Speaker: Doctor M. Berger (Aachen, DE)

Access the full session

Renal failure and clinical outcomes

Speakers: Doctor S. Ohshima, Mr E. Bakbak, Doctor J. Zeng, Doctor M. Klaric, Doctor B. Tyl...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources